| 2026 |
| 06/19 | 116 | 116 | 103 | 105 | -7.89% | 1,081,200 | 47億7600万 | -16.67% |
| 06/18 | 119 | 119 | 111 | 114 | -3.39% | 834,400 | 51億8537万 | -10.24% |
| 06/17 | 118 | 122 | 118 | 118 | -0.84% | 301,100 | 53億6732万 | -7.81% |
| 06/17 | (空売り報告)Barclays Capital Securities Ltd 543,900株(1.19%)-0.01% |
| 06/16 | 121 | 121 | 117 | 119 | -0.83% | 166,300 | 54億1280万 | -8.46% |
| 06/15 | 119 | 122 | 118 | 120 | +2.56% | 237,400 | 54億5829万 | -8.4% |
| 06/12 | 118 | 119 | 116 | 117 | 0% | 160,600 | 53億2183万 | -11.36% |
| 06/11 | 118 | 118 | 115 | 117 | -0.85% | 195,700 | 53億2183万 | -12.03% |
| 06/11 | (空売り報告)Barclays Capital Securities Ltd 506,300株(1.11%)+0.06% |
| 06/10 | 118 | 118 | 113 | 118 | 0% | 607,600 | 53億6732万 | -11.94% |
| 06/10 | (空売り報告)Barclays Capital Securities Ltd 480,000株(1.05%)+0.09% |
| 06/09 | 121 | 121 | 117 | 118 | -1.67% | 418,900 | 53億6732万 | -13.24% |
| 06/09 | (空売り報告)Barclays Capital Securities Ltd 441,400株(0.96%)+0.13% |
| 06/08 | 119 | 123 | 119 | 120 | -3.23% | 380,700 | 54億5829万 | -12.41% |
| 06/08 | (空売り報告)Barclays Capital Securities Ltd 381,000株(0.83%)+0.06% |
| 06/05 | 121 | 125 | 121 | 124 | +3.33% | 243,200 | 56億4023万 | -10.14% |
| 06/05 | (空売り報告)Barclays Capital Securities Ltd 352,200株(0.77%)-0.06% |
| 06/04 | 122 | 123 | 119 | 120 | -1.64% | 365,600 | 54億5829万 | -13.67% |
| 06/03 | 128 | 128 | 122 | 122 | -3.94% | 564,100 | 55億4926万 | -12.86% |
| 06/03 | (空売り報告)Barclays Capital Securities Ltd 380,239株(0.83%)+0.08% |
| 06/02 | 127 | 129 | 126 | 127 | -1.55% | 173,300 | 57億7669万 | -9.93% |
| 06/01 | (IR情報)15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 06/01 | 130 | 131 | 126 | 129 | -0.77% | 419,200 | 58億6766万 | -9.15% |
| 05/29 | 132 | 134 | 129 | 130 | -2.26% | 160,600 | 59億1314万 | -9.09% |
| 05/29 | (空売り報告)Barclays Capital Securities Ltd 342,239株(0.75%)+0.13% |
| 05/28 | 131 | 136 | 131 | 133 | -1.48% | 328,200 | 60億4960万 | -6.99% |
| 05/28 | (空売り報告)Barclays Capital Securities Ltd 286,439株(0.62%)+0.08% |
| 05/27 | 133 | 135 | 131 | 135 | +2.27% | 191,200 | 61億4057万 | -6.25% |
| 05/26 | 134 | 134 | 130 | 132 | -2.22% | 323,100 | 60億412万 | -8.33% |
| 05/25 | 137 | 137 | 132 | 135 | -2.17% | 355,500 | 61億4057万 | -6.25% |
| 05/25 | (空売り報告)Barclays Capital Securities Ltd 249,500株(0.54%)再IN |
| 05/22 | 138 | 139 | 136 | 138 | +0.73% | 180,900 | 62億7703万 | -4.17% |
| 05/21 | 139 | 139 | 136 | 137 | 0% | 111,000 | 62億3155万 | -4.86% |
| 05/20 | 142 | 143 | 133 | 137 | -3.52% | 504,700 | 62億3155万 | -4.86% |
| 05/19 | 139 | 144 | 139 | 142 | +2.16% | 106,200 | 64億5897万 | -2.07% |
| 05/18 | 140 | 141 | 136 | 139 | -0.71% | 273,500 | 63億2252万 | -4.14% |
| 05/15 | (IR情報)15:30 2026年12月期第1四半期決算短信〔日本基準〕(非連結) |
| 05/15 | 144 | 146 | 140 | 140 | -3.45% | 473,700 | 63億6800万 | -3.45% |
| 05/14 | 145 | 147 | 144 | 145 | +0.69% | 89,100 | 65億9543万 | 0% |
| 05/13 | 146 | 146 | 144 | 144 | -1.37% | 131,300 | 65億4995万 | 0% |
| 05/12 | (IR情報)17:20 ストック・オプションとしての新株予約権の発行内容確定に関するお知らせ |
| 05/12 | 150 | 152 | 146 | 146 | -1.35% | 247,400 | 66億4092万 | +1.39% |
| 05/11 | 150 | 150 | 148 | 148 | -1.99% | 215,600 | 67億3189万 | +2.78% |
| 05/08 | 150 | 153 | 149 | 151 | 0% | 200,700 | 68億6835万 | +4.86% |
| 05/07 | 149 | 154 | 148 | 151 | +2.03% | 280,300 | 68億6835万 | +5.59% |
| 05/01 | (IR情報)15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 05/01 | 149 | 151 | 147 | 148 | 0% | 217,500 | 67億3189万 | +3.5% |
| 04/30 | 149 | 149 | 145 | 148 | -1.33% | 232,200 | 67億3189万 | +4.23% |
| 04/28 | 150 | 151 | 146 | 150 | 0% | 321,400 | 68億2286万 | +5.63% |
| 04/27 | 143 | 154 | 143 | 150 | +4.17% | 767,000 | 68億2286万 | +5.63% |
| 04/24 | (IR情報)15:30 お問い合わせいただいたご質問に対する回答および第22回定時株主総会での質疑応答内容のお知らせ |
| 04/24 | 145 | 146 | 142 | 144 | 0% | 258,800 | 65億4995万 | +2.13% |
| 04/23 | 147 | 148 | 144 | 144 | -2.7% | 268,500 | 65億4995万 | +2.13% |
| 04/22 | 149 | 149 | 146 | 148 | -1.33% | 164,800 | 67億3189万 | +4.96% |
| 04/21 | 145 | 150 | 145 | 150 | +3.45% | 789,600 | 68億2286万 | +6.38% |
| 04/20 | 143 | 147 | 143 | 145 | +2.11% | 396,400 | 65億9543万 | +2.84% |
| 04/17 | 139 | 144 | 139 | 142 | +1.43% | 177,800 | 64億5897万 | +0.71% |
| 04/16 | 141 | 143 | 139 | 140 | 0% | 144,800 | 63億6800万 | -1.41% |
| 04/15 | (IR情報)15:30 ストック・オプションとしての新株予約権の発行に関するお知らせ |
| 04/15 | 141 | 142 | 139 | 140 | -0.71% | 106,100 | 63億6800万 | -1.41% |
| 04/14 | 139 | 142 | 138 | 141 | +1.44% | 124,800 | 64億1349万 | -1.4% |
| 04/13 | 139 | 140 | 138 | 139 | -0.71% | 126,000 | 63億2252万 | -2.8% |
| 04/10 | 139 | 142 | 138 | 140 | +0.72% | 232,900 | 63億6800万 | -2.1% |
| 04/09 | 142 | 142 | 138 | 139 | -2.11% | 236,800 | 63億2252万 | -2.8% |
| 04/08 | 139 | 142 | 139 | 142 | +2.9% | 136,500 | 64億5897万 | -0.7% |
| 04/07 | 140 | 142 | 137 | 138 | -1.43% | 259,600 | 62億7703万 | -4.17% |
| 04/06 | 141 | 141 | 139 | 140 | -0.71% | 69,100 | 63億6800万 | -2.78% |
| 04/03 | 140 | 142 | 137 | 141 | 0% | 184,500 | 64億1349万 | -2.08% |
| 04/02 | 143 | 145 | 139 | 141 | -0.7% | 102,000 | 64億1349万 | -2.76% |
| 04/01 | (IR情報)15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 04/01 | 142 | 143 | 139 | 142 | +3.65% | 147,100 | 64億5897万 | -2.07% |
| 03/31 | 138 | 139 | 136 | 137 | -0.72% | 171,100 | 62億3155万 | -5.52% |
| 03/30 | (IR情報)15:30 事業計画及び成長可能性に関する事項 |
| 03/30 | 137 | 139 | 136 | 138 | -1.43% | 159,700 | 62億7703万 | -4.83% |
| 03/27 | (IR情報)15:30 資金の充当予定時期の変更に関するお知らせ |
| 03/27 | 136 | 142 | 136 | 140 | +1.45% | 125,100 | 63億6800万 | -4.11% |
| 03/26 | (IR情報)17:00 日本薬学会第146年会でのSMTPに関する発表のお知らせ |
| 03/26 | 144 | 144 | 137 | 138 | -4.83% | 278,700 | 62億7703万 | -5.48% |
| 03/25 | 142 | 145 | 142 | 145 | +2.11% | 159,600 | 65億9543万 | 0% |
| 03/24 | 141 | 143 | 139 | 142 | +2.9% | 125,100 | 64億5897万 | -2.07% |
| 03/23 | 138 | 140 | 136 | 138 | -2.82% | 423,200 | 62億7703万 | -4.83% |
| 03/19 | 147 | 147 | 142 | 142 | -4.7% | 337,700 | 64億5897万 | -2.07% |
| 03/18 | 146 | 149 | 145 | 149 | +2.05% | 150,100 | 67億7737万 | +2.76% |
| 03/17 | 150 | 151 | 144 | 146 | -2.01% | 296,300 | 66億4092万 | +0.69% |
| 03/16 | (IR情報)15:30 第51回日本脳卒中学会学術集会でのSMTPに関する発表のお知らせ |
| 03/16 | 145 | 149 | 144 | 149 | +1.36% | 201,200 | 67億7737万 | +2.76% |
| 03/13 | 146 | 148 | 144 | 147 | -2% | 181,300 | 66億8640万 | +1.38% |
| 03/12 | 150 | 151 | 146 | 150 | -0.66% | 581,600 | 68億2286万 | +3.45% |
| 03/11 | (IR情報)15:30 国立大学法人九州大学との急性腎障害予防・治療薬の共同研究開始のお知らせ |
| 03/11 | 151 | 154 | 149 | 151 | -3.21% | 369,800 | 68億6835万 | +4.14% |
| 03/10 | 150 | 165 | 148 | 156 | +5.41% | 1,578,700 | 70億9577万 | +7.59% |
| 03/09 | 138 | 148 | 135 | 148 | +3.5% | 650,800 | 67億3189万 | +2.07% |
| 03/06 | 142 | 146 | 142 | 143 | -0.69% | 178,700 | 65億446万 | -1.38% |
| 03/05 | 139 | 145 | 139 | 144 | +6.67% | 302,600 | 65億4995万 | -0.69% |
| 03/04 | 144 | 144 | 134 | 135 | -8.78% | 856,600 | 61億4057万 | -6.9% |
| 03/03 | 148 | 150 | 145 | 148 | +0.68% | 698,800 | 67億3189万 | +1.37% |
| 03/02 | (IR情報)15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 03/02 | (IR情報)15:30 日本農芸化学会の学会誌「化学と生物」へ取締役会長の蓮見が巻頭コラムを寄稿しました |
| 03/02 | 150 | 152 | 147 | 147 | -5.16% | 643,000 | 66億8640万 | +0.68% |
| 02/27 | 150 | 157 | 148 | 155 | +2.65% | 667,000 | 70億5029万 | +6.16% |
| 02/26 | 148 | 151 | 146 | 151 | +2.03% | 510,700 | 68億6835万 | +3.42% |
| 02/25 | 142 | 151 | 141 | 148 | +2.78% | 580,200 | 67億3189万 | +1.37% |
| 02/24 | 142 | 144 | 139 | 144 | +1.41% | 320,100 | 65億4995万 | -1.37% |
| 02/20 | (IR情報)15:30 2025年12月期決算説明会の動画公開のお知らせ |
| 02/20 | 142 | 149 | 138 | 142 | +0.71% | 1,089,900 | 64億5897万 | -2.74% |
| 02/19 | (IR情報)15:30 TMS-007(JX10)ORION(第2⁄3相)臨床試験の日本コホートにおける最初の被験者への投与のお知らせ |
| 02/19 | 142 | 142 | 139 | 141 | -0.7% | 109,900 | 64億1349万 | -4.08% |
| 02/18 | 135 | 144 | 134 | 142 | +6.77% | 464,700 | 64億5897万 | -3.4% |
| 02/18 | (空売り報告)Barclays Capital Securities Ltd 191,500株(0.42%)-0.08%義務消失 |
| 02/17 | 138 | 139 | 133 | 133 | -2.92% | 367,200 | 60億4960万 | -9.52% |
| 02/16 | 137 | 139 | 134 | 137 | -2.14% | 457,100 | 62億3155万 | -7.43% |
| 02/16 | (空売り報告)Barclays Capital Securities Ltd 229,239株(0.5%)再IN |
| 02/13 | (IR情報)15:30 2025年12月期決算説明資料 |
| 02/13 | (IR情報)15:30 2025年12月期決算短信〔日本基準〕(非連結) |
| 02/13 | 140 | 142 | 138 | 140 | -2.1% | 183,100 | 63億6800万 | -5.41% |
| 02/12 | 143 | 143 | 141 | 143 | 0% | 119,000 | 65億446万 | -3.38% |
| 02/10 | 140 | 143 | 140 | 143 | +2.14% | 136,300 | 65億446万 | -3.38% |
| 02/10 | (空売り報告)Barclays Capital Securities Ltd 198,400株(0.43%)-0.08%義務消失 |
| 02/09 | 143 | 143 | 139 | 140 | -1.41% | 190,900 | 63億6800万 | -4.76% |
| 02/09 | (空売り報告)Barclays Capital Securities Ltd 233,800株(0.51%)再IN |
| 02/06 | 146 | 146 | 140 | 142 | -2.07% | 251,000 | 64億5897万 | -3.4% |
| 02/05 | 148 | 150 | 145 | 145 | -2.03% | 313,400 | 65億9543万 | -0.68% |
| 02/04 | (5%ルール)東北大学ベンチャーパートナーズ(5.18%) |
| 02/04 | 150 | 150 | 148 | 148 | -1.33% | 79,500 | 67億3189万 | +1.37% |
| 02/03 | 149 | 150 | 148 | 150 | +0.67% | 115,700 | 68億2286万 | +3.45% |
| 02/02 | (IR情報)15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 02/02 | 153 | 153 | 148 | 149 | -3.87% | 258,900 | 67億7737万 | +3.47% |
| 01/30 | 150 | 155 | 149 | 155 | +2.65% | 306,100 | 70億5029万 | +8.39% |
| 01/29 | 149 | 151 | 147 | 151 | +0.67% | 250,000 | 68億6835万 | +6.34% |
| 01/29 | (空売り報告)Barclays Capital Securities Ltd 206,800株(0.45%)-0.08%義務消失 |
| 01/28 | 149 | 150 | 146 | 150 | 0% | 173,400 | 68億2286万 | +6.38% |
| 01/27 | 150 | 151 | 148 | 150 | 0% | 248,700 | 68億2286万 | +7.14% |
| 01/27 | (空売り報告)Barclays Capital Securities Ltd 243,600株(0.53%)再IN |
| 01/26 | 150 | 152 | 150 | 150 | -0.66% | 201,100 | 68億2286万 | +7.14% |
| 01/26 | (空売り報告)Barclays Capital Securities Ltd 223,039株(0.49%)-0.01%義務消失 |
| 01/23 | 147 | 155 | 147 | 151 | +2.03% | 305,300 | 68億6835万 | +8.63% |
| 01/23 | (空売り報告)Barclays Capital Securities Ltd 229,600株(0.5%)-0.11% |
| 01/22 | 148 | 149 | 146 | 148 | +0.68% | 155,100 | 67億3189万 | +7.25% |
| 01/21 | (IR情報)15:30 SMTP化合物に関する共同研究論文掲載のお知らせ |
| 01/21 | (空売り報告)Barclays Capital Securities Ltd 279,361株(0.61%)+0.07% |
| 01/20 | (空売り報告)Barclays Capital Securities Ltd 249,600株(0.54%)再IN |
| 01/19 | (空売り報告)Barclays Capital Securities Ltd 202,600株(0.44%)-0.06%義務消失 |
| 01/16 | (空売り報告)Barclays Capital Securities Ltd 229,400株(0.5%)再IN |